Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

Canaccord reiterates Jazz Pharmaceuticals stock rating on trial data - investing.com

news.google.com · 01 Sep 2026

Google News – Biopharma External News

RedHill Biopharma (RDHL) Secures Exclusive Commercialization Rig - GuruFocus

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Redefining the standard for recessed lighting in the pharmaceutical industry - European Pharmaceutical Review

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Collaborations Pharmaceuticals and RTI International awarded an SBIR for long-acting treatment for HIV - EIN News

news.google.com · 01 Sep 2026

Google News – Biopharma External News

RedHill Biopharma (RDHL) Acquires Commercial Rights for Rebyota and Clenpiq, Faces Valuation Challenges - GuruFocus

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Is Amylyx Pharmaceuticals (AMLX) Expensive As Phase 3 Avexitide Data Clears The Way? - simplywall.st

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - PR Newswire

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - prnewswire.com

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Novartis pauses trials of experimental cell therapy after three deaths - PharmaLive

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals - The National Law Review

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times

news.google.com · 01 Sep 2026

Google News – Clinical Trials External News

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer - PR Newswire

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Is Arrowhead Pharmaceuticals (ARWR) Undervalued As SHASTA 3 And SHASTA 4 Data Impress? - Yahoo Finance

news.google.com · 01 Sep 2026

Google News – Pharmaceuticals External News

Enanta Pharmaceuticals to Participate in September Investor Conferences - Yahoo Finance

news.google.com · 01 Sep 2026

News & Articles

The 90-Day Capability Reset for Healthcare Employers

The Decision Architecture Skill Clinical Research Teams Need

Beta Bionics’ insulin patch pump gets FDA nod

HR must set boundaries as it embraces AI notetakers, experts caution

Staff slept while patient killed at NHS mental health unit

Hong Kong parents urged to vaccinate young children amid rising summer flu cases

PEN-Plus operations manual

Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions

Responsible spending starts with timely access, informed choices and more connected care

The future of talent sourcing is more than clicks

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Lakeland Community Hospital receives grant to expand rural healthcare access - alreporter.com

Stryker stock falls on slower peripheral vascular, hip sales

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

Canaccord reiterates Jazz Pharmaceuticals stock rating on trial data - investing.com

RedHill Biopharma (RDHL) Secures Exclusive Commercialization Rig - GuruFocus

Redefining the standard for recessed lighting in the pharmaceutical industry - European Pharmaceutical Review

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

Collaborations Pharmaceuticals and RTI International awarded an SBIR for long-acting treatment for HIV - EIN News

RedHill Biopharma (RDHL) Acquires Commercial Rights for Rebyota and Clenpiq, Faces Valuation Challenges - GuruFocus

Is Amylyx Pharmaceuticals (AMLX) Expensive As Phase 3 Avexitide Data Clears The Way? - simplywall.st

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - PR Newswire

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy - prnewswire.com

Novartis pauses trials of experimental cell therapy after three deaths - PharmaLive

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals - The National Law Review

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer - PR Newswire

Is Arrowhead Pharmaceuticals (ARWR) Undervalued As SHASTA 3 And SHASTA 4 Data Impress? - Yahoo Finance

Enanta Pharmaceuticals to Participate in September Investor Conferences - Yahoo Finance